Clinical characteristics, medical service utilization, and expenditure for colorectal cancer in China, 2005 to 2014: Overall design and results from a multicenter retrospective epidemiologic survey

Jufang Shi(Chinese Academy of Medical Sciences & Peking Union Medical College), Le Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Jian‐Chao Ran(Xinjiang Medical University), Hong Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Chengcheng Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Haizeng Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Lin Yang(Guangxi Medical University), Su‐Sheng Shi(Chinese Academy of Medical Sciences & Peking Union Medical College), Liming Jiang(Chinese Academy of Medical Sciences & Peking Union Medical College), Jin‐Hu Fan(Chinese Academy of Medical Sciences & Peking Union Medical College), Yue‐Ming Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Weihu Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Jiansong Ren(Chinese Academy of Medical Sciences & Peking Union Medical College), Lin Zhu(Xinjiang Medical University), Zhaoxu Zheng(Chinese Academy of Medical Sciences & Peking Union Medical College), Yongkun Sun(Chinese Academy of Medical Sciences & Peking Union Medical College), Shuangmei Zou(Chinese Academy of Medical Sciences & Peking Union Medical College), Jun Jiang(Chinese Academy of Medical Sciences & Peking Union Medical College), Bo Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Hongda Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Guoxiang Liu(Harbin Medical University), Li Yang(Guangxi Medical University), Yunchao Huang, Lan‐Wei Guo(Zhengzhou University), Debin Wang(Anhui Medical University), Yong‐Zhen Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Ayan Mao(Chinese Academy of Medical Sciences & Peking Union Medical College), Jialin Wang(Shandong University), Jiyong Gong(Shandong University), Donghua Wei(Anhui Provincial Hospital), Wu‐Qi Qiu(Chinese Academy of Medical Sciences & Peking Union Medical College), Bingbing Song(Harbin Medical University), Kai Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Ni Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Eleonora Feletto(Cancer Council NSW), Jie‐Bin Lew(Cancer Council NSW), You‐Lin Qiao(Chinese Academy of Medical Sciences & Peking Union Medical College), Wanqing Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Min Dai(Chinese Academy of Medical Sciences & Peking Union Medical College), Jie He(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cancer
March 30, 2021
Cited by 106Open Access
Full Text

Abstract

BACKGROUND: Colorectal cancer (CRC) is the third most common cancer in China, however, publicly available, descriptive information on the clinical epidemiology of CRC is limited. METHODS: Patients diagnosed with primary CRC during 2005 through 2014 were sampled from 13 tertiary hospitals in 9 provinces across China. Data related to sociodemographic characteristics, the use of diagnostic technology, treatment adoption, and expenditure were extracted from individual medical records. RESULTS: In the full cohort of 8465 patients, the mean ± SD age at diagnosis was 59.3 ± 12.8 years, 57.2% were men, and 58.7% had rectal cancer. On average, 14.4% of patients were diagnosed with stage IV disease, and this proportion increased from 13.5% in 2005 to 20.5% in 2014 (P value for trend < .05). For diagnostic techniques, along with less use of x-rays (average, 81.6%; decreased from 90.0% to 65.7%), there were increases in the use of computed tomography (average, 70.4%; increased from 4.5% to 90.5%) and magnetic resonance imaging (average, 8.8%; increased from 0.1% to 20.4%) over the study period from 2005 to 2014. With regard to treatment, surgery alone was the most common (average, 50.1%), but its use decreased from 51.3% to 39.8% during 2005 through 2014; and the use of other treatments increased simultaneously, such as chemotherapy alone (average, 4.1%; increased from 4.1% to 11.9%). The average medical expenditure per patient was 66,291 Chinese Yuan (2014 value) and increased from 47,259 to 86,709 Chinese Yuan. CONCLUSIONS: The increasing proportion of late-stage diagnoses presents a challenge for CRC control in China. Changes in diagnostic and treatment options and increased expenditures are clearly illustrated in this study. Coupled with the recent introduction of screening initiatives, these data provide an understanding of changes over time and may form a benchmark for future related evaluations of CRC interventions in China.


Related Papers

No related papers found

Powered by citation graph analysis